AstraZeneca Faces USD4.5M Fine Over Import Tax Evasion

文章预览

▲ Click above to subscribe   点击上方蓝字关注我们 AstraZeneca, the UK-Swedish pharmaceutical giant caught in a regulatory storm in China since last year, said it could face a fine of up to USD4.5 million in China over suspected unpaid drug import taxes. AstraZeneca received a Notice of Transfer to the Prosecutor and an Appraisal Opinion from the Shenzhen City Customs Office regarding suspected unpaid importation taxes of USD900,000 in January, the firm said in a financial report yesterday. The import taxes relate to oncological drugs Imfinzi and Imjudo, it added. AstraZeneca will be levied a fine of between one and five times the amount of unpaid import taxes if found liable, it noted, adding that it continues to fully cooperate with Chinese authorities. Last October, Leon Wang, former China president of AstraZeneca, was detained by Chinese authorities for investigation on a large-scale medical insurance fraud committed by former employees, sparking a regulatory storm. T ………………………………